Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 2
2010 2
2011 5
2012 1
2013 4
2014 3
2015 2
2016 4
2017 6
2018 7
2019 6
2020 3
2021 2
2022 1
2023 5
2024 6
2025 11
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study).
McAllister-Williams RH, Goudie N, Azim L, Bartle V, Berger M, Butcher C, Chadwick T, Clare E, Courtney P, Dixon L, Duffelen N, Fouweather T, Gann W, Geddes J, Gupta S, Hall B, Helter T, Hindmarch P, Holstein EM, Lawrence W, Mawson P, McKinnon I, Milne A, Molloy A, Moore A, Morriss R, Nakulan A, Simon J, Smith D, Stokes-Crossley B, Stokes PR, Swain A, Taiwo A, Walmsley Z, Weetman C, Young AH, Watson S. McAllister-Williams RH, et al. Among authors: courtney p. J Psychopharmacol. 2025 Feb;39(2):106-120. doi: 10.1177/02698811241309622. Epub 2025 Jan 20. J Psychopharmacol. 2025. PMID: 39829389 Free PMC article. Clinical Trial.
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trial.
Berger M, Helter T, Azim L, Chadwick T, Courtney P, Fouweather T, Geddes J, Hindmarch P, Morriss R, Stokes PRA, Watson S, Weetman C, Young AH, McAllister-Williams RH, Simon J. Berger M, et al. Among authors: courtney p. J Affect Disord. 2025 Dec 15;391:119937. doi: 10.1016/j.jad.2025.119937. Epub 2025 Jul 18. J Affect Disord. 2025. PMID: 40683533 Free article. Clinical Trial.
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.
McAllister-Williams H, Goudie N, Azim L, Bartle V, Berger M, Butcher C, Chadwick T, Clare E, Courtney P, Dixon L, Duffelen N, Fouweather T, Gann W, Geddes J, Gupta S, Hall B, Helter T, Hindmarch P, Holstein EM, Lawrence W, Mawson P, McKinnon I, Milne A, Molloy A, Moore A, Morriss R, Nakulan A, Simon J, Smith D, Stokes-Crossley B, Stokes P, Swain A, Walmsley Z, Weetman C, Young AH, Watson S. McAllister-Williams H, et al. Among authors: courtney p. Health Technol Assess. 2025 May;29(21):1-216. doi: 10.3310/HBFC1953. Health Technol Assess. 2025. PMID: 40455248 Free PMC article. Clinical Trial.
59 results